Clinical Trial Update: Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating gemcitabine, carboplatin, and panitumumab (GCaP) as neoadjuvant chemotherapy for muscle-invasive bladder cancer was terminated; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemzar (gemcitabine)
• Vectibix (panitumumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Bladder Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-02-12